blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3831375

EP3831375 - RAPID RELIEF OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  19.08.2022
Database last updated on 15.11.2024
FormerRequest for examination was made
Status updated on  10.12.2021
FormerThe application has been published
Status updated on  07.05.2021
Most recent event   Tooltip30.08.2024Change: Appeal number 
Applicant(s)For all designated states
Civitas Therapeutics, Inc.
420 Saw Mill River Road
Ardsley, NY 10502 / US
[2021/48]
Former [2021/23]For all designated states
Civitas Therapeutics, Inc.
190 Everett Ave.
Chelsea, MA 02150 / US
Inventor(s)01 / BATYCKY, Richard P.
11 Madison Avenue
Newton, MA 02460 / US
02 / FREED, Martin
15 Standish Circle Wellesley
MA, 02481 / US
03 / LIPP, Michael M.
45a Flanagan Drive
Framingham, MA 01710 / US
 [2021/23]
Representative(s)Lee, Nicholas John, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2021/23]
Application number, filing date21150770.221.04.2014
[2021/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3831375
Date:09.06.2021
Language:EN
[2021/23]
Search report(s)(Supplementary) European search report - dispatched on:EP22.04.2021
ClassificationIPC:A61K31/198, A61K9/14, A61K9/48, A61P25/16
[2021/23]
CPC:
A61K31/198 (EP,IL,KR,US); A61K9/14 (RU); A61K9/0075 (EP,IL,KR,US);
A61P25/16 (EP,IL,RU)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/02]
Former [2021/23]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:SCHNELLE LINDERUNG VON MOTORISCHEN FLUKTUATIONEN BEI MORBUS PARKINSON[2021/23]
English:RAPID RELIEF OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE[2021/23]
French:SOULAGEMENT RAPIDE DES FLUCTUATIONS MOTRICES DANS LA MALADIE DE PARKINSON[2021/23]
Examination procedure07.12.2021Amendment by applicant (claims and/or description)
07.12.2021Examination requested  [2022/02]
07.12.2021Date on which the examining division has become responsible
19.08.2022Despatch of a communication from the examining division (Time limit: M06)
22.03.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
01.06.2023Reply to a communication from the examining division
04.04.2024Cancellation of oral proceeding that was planned for 04.06.2024
23.04.2024Despatch of communication that the application is refused, reason: substantive examination {1}
04.06.2024Date of oral proceedings (cancelled)
Appeal following examination21.06.2024Appeal received No.  T1120/24
21.06.2024Payment of appeal fee
23.08.2024Statement of grounds filed
Parent application(s)   TooltipEP14889874.5  / EP3134077
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
01.06.2023Request for further processing filed
01.06.2023Full payment received (date of receipt of payment)
Request granted
12.06.2023Decision despatched
Fees paidRenewal fee
30.03.2021Renewal fee patent year 03
30.03.2021Renewal fee patent year 04
30.03.2021Renewal fee patent year 05
30.03.2021Renewal fee patent year 06
30.03.2021Renewal fee patent year 07
15.04.2021Renewal fee patent year 08
28.03.2022Renewal fee patent year 09
27.04.2023Renewal fee patent year 10
12.04.2024Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]GB2454480  (VECTURA GROUP PLC [GB]) [Y] 1-8 * page 4, line 30 - page 5, line 2 * * page 5, lines 16-21 * * page 9, lines 15-27 * * page 10, lines 20-26 * * page 34, lines 29-31 * * page 37, lines 11-17 * * claims 1, 3, 4, 10, 14, 18 *;
 [Y]US8404276  (JACKSON BLAIR [US], et al) [Y] 1-8 * column 5; tables 1, 2 * * column 16, lines 60-64 * * column 17; example 4 * * claims 7-12 *;
 [T]WO2014066208  (CIVITAS THERAPEUTICS INC [US]) [T] * page 13, lines 11-15 * * page 29, line 15 - page 20, line 29 * * claim 32 ** figure 8 *;
 [Y]  - Anonymous, "Inhaled Levodopa as a Treatment for Intermittent Motor Fluctuations in Parkinson's Disease", (20140301), pages 1 - 2, URL: https://www.michaeljfox.org/foundation/grant-detail.php?grant_id=1176, (20171109), XP055423106 [Y] 1-8 * the whole document *
 [A]  - MARTIN FREED ET AL, "Rapid Levodopa Augmentation Following Inhaled CVT-301 Results in Rapid Improvement in Motor Response When Administered to PD Patients in the OFF State (S7,007)", NEURO, LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, US, vol. 82, no. 10, ISSN 0028-3878, (20140408), pages 1 - 2, (20140408), XP008184053 [A] 1-8 * the whole document *
 [Y]  - Nate Herpich, "A Breath of Relief: Inhaled Formulation of Levodopa Reduces 'Off' Periods in People with Parkinson's", Foxfeed Blog, (20130419), pages 1 - 2, URL: https://www.michaeljfox.org/foundation/news-detail.php?breath-of-relief-inhaled-formulation-of-levodopa-reduces-off-periods-in-people-with-parkinson, (20171109), XP055423098 [Y] 1-8 * the whole document *
 [Y]  - Anonymous, "NCT01617135 on 2013_06_13: Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes", ClinicalTrials.gov Archive, (20130613), pages 1 - 3, URL: https://clinicaltrials.gov/archive/NCT01617135/2013_06_13, (20171109), XP055423097 [Y] 1-8 * the whole document *
 [AP]  - Anonymous, "CVT-inhaled levodopa for the treatment of Parkinson's disease - Civitas Therapeutics Announces Positive Phase 2b Results for CVT-301, Inhaled Levodopa for the Treatment of Parkinson's Disease", (20140428), pages 1 - 7, URL: http://www.fh-partners.com/news-entries/2014/4/28/civitas-therapeutics-announces-positive-phase-2b-results-for-cvt-301-inhaled-levodopa-for-the-treatment-of-parkinsons-disease, (20171109), XP055423101 [AP] 1-8 * page 1, paragraph l - page 2, paragraph 3 * * page 2, paragraph l - page 3, paragraph 2 *
by applicantUS6254854
 US6514482
 US6858199
 US7556798
 USRE43711E
 US8496002
    - KAWAGUCHI, H. et al., Biomaterials, (19860000), vol. 7, pages 61 - 66
    - KRENIS, L.J.STRAUSS, B., Proc. Soc. Exp. Med., (19610000), vol. 107, pages 748 - 750
    - RUDT, S.MULLER, R.H., J. Contr. Rel., (19920000), vol. 22, pages 263 - 272
    - EDWARDS, D.A., J. Aerosol Sci., (19950000), vol. 26, pages 293 - 317
    - "Physico-chemical principles in aerosol delivery", GONDA, I, Topics in Pharmaceutical Sciences, Medpharm Scientific Publishers, (19910000), pages 95 - 117
    - HEYDER, J. et al., J. Aerosol Sci., (19860000), vol. 17, pages 811 - 825
    - VISSER, J., Powder Technology, vol. 58, pages 1 - 10
    - SHULMAN et al., Arch Neurol, (20100100), vol. 67
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.